Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | NSD2 | O96028 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27333040 | 0.98 | ALDH1A1 (0.53) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| Hydrochloric Acid SCHEMBL28095718 | 0.98 | ALDH1A1 (0.53) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| SCHEMBL28203165 | 0.94 | ALDH1A1 (0.50) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| SCHEMBL18900607 | 0.88 | ALDH1A1 (0.51) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| Methyl Orange SCHEMBL16163325 | 0.88 | NPC1 (0.69) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| Methyl Orange SCHEMBL296471 | 0.88 | NPC1 (0.69) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| SCHEMBL16667874 | 0.88 | CA2 (0.51) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| Methyl Orange SCHEMBL296472 | 0.88 | NPC1 (0.69) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| Methyl Orange SCHEMBL19662 | 0.87 | NPC1 (0.67) | ALDH1A1ALOX15HSD17B10HPGDKDM4E | |
| SCHEMBL11594922 | 0.87 | TSHR (0.53) | ALDH1A1ALOX15HSD17B10HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116103711-A | Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating | 安徽智备工业科技有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-112881311-A | Creatine kinase detection reagent, kit and detection method | 深圳迈瑞生物医疗电子股份有限公司 | 2021-06-01 | — | — | CN | claimed |
| WO-2012168458-A1 | ZWITTERIONIC COMPOUNDS USEFUL AS CATALYSTS FOR ESTERIFICATION REACTIONS AND PROCESSES FOR THEIR PRODUCTION | ECOSYNTH BVBA (BE) | 2012-12-13 | — | — | WO | claimed |
| CN-120944201-A | Insole rubber composite modified material and preparation method thereof | 广东乐骏新材料有限公司 | 2025-11-14 | — | — | CN | disclosed |
| US-11718641-B2 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | ENANTA PHARMACEUTICALS, INC. (US) | 2023-08-08 | — | — | US | disclosed |
| US-11718641-B2 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | ENANTA PHARMACEUTICALS, INC. (US) | 2023-08-08 | — | — | US | disclosed |
| CN-116103711-A | Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating | 安徽智备工业科技有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-112694880-B | Surfactant composition containing aniline compound for oil displacement, and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115160301-A | Diphyllin derivative, preparation method and application thereof | 上海交通大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-110317137-B | 9, 10-anthraquinone compound or pharmaceutically acceptable salt thereof and pharmaceutical application thereof | 复旦大学 | 2022-04-19 | — | — | CN | disclosed |
| CN-111362829-B | Minocycline di-p-chlorobenzenesulfonate crystal form and preparation method and application thereof | 浙江昌海制药有限公司 | 2021-11-30 | — | — | CN | disclosed |
| EP-0254950-A2 | (Meth-)acrylic esters | BAYER AG (DE) | 1988-02-03 | — | — | EP | disclosed |
| EP-0254263-A2 | (Meth)acrylic acid derivatives containing urethane groups | BAYER AG (DE) | 1988-01-27 | — | — | EP | disclosed |
| EP-0254185-A1 | (Meth)acrylic acid derivatives of tricyclo[5.2.1.02.6]decanes containing urethane groups | BAYER AG (DE) | 1988-01-27 | — | — | EP | disclosed |
| US-4698445-A | ANTIARRHYTHMIA AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-10-06 | — | — | US | disclosed |
| US-4692548-A | DIMERIZATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | SHELL OIL COMPANY (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0206367-A2 | Process for the dimerization of ethylenically unsaturated compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-12-30 | — | — | EP | disclosed |
| EP-0188830-A1 | Process for the preparation of dimerization products from olefins | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-07-30 | — | — | EP | disclosed |
| US-4599476-A | PALLADIUM OR RUTHENIUM CATALYST | SHELL OIL COMPANY (US) | 1986-07-08 | — | — | US | disclosed |
| CN-85109193-A | With alkene is the method for feedstock production dimerisation products | — | 1986-06-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718641-B2 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | GPBAR1, NR1H4, SLC10A1 | ALDH1A1 2372/4885ALOX15 454/4885HSD17B10 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.